Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 724

Kytopen sparks $3.6m reaction

Kytopen, the developer of a cell therapy manufacturing platform based on MIT research, has been backed by MIT’s The Engine for a second time.

May 30, 2019

Purdue-linked trio pick up funding

Biotech developers Animated Dynamics, Predictive Wear and Brightlamp have all secured commitments worth up to $250,000 from Foundry Investment Fund.

May 30, 2019

Vector boxes up $12m

Road freight documentation platform Vector has closed its Congruent Ventures-backed series A at $12m, adding $2m to the initial close reported last month.

May 30, 2019

Columbia pumps intellectual property into Tara Biosystems

Columbia University has granted a new licence to its cardiovascular research platform spinout Tara Biosystems, which markets services powered by is "heart-on-a-chip" tissue modelling system.

May 30, 2019

Kapost travels to Upland in $45m deal

Salesforce Ventures has exited the content marketing platform in an acquisition by Upland Software that follows some $22m in funding.

May 30, 2019

SoFi sorts out another $500m

SoftBank and Renren-backed online financial services provider SoFi is now valued at $4.8bn following a $500m round led by QIA.

May 30, 2019

Palo Alto Networks secures Twistlock in $410m acquisition

Dell Technologies Capital will exit container cybersecurity technology provider Twistlock in an acquisition by Palo Alto Networks that follows $63m of funding.

May 30, 2019

Avalanche rocks $33m round

Corporate-backed RAM memory product developer Avalanche Technology has now raised more than $100m, its earlier backers including Qualcomm, VTB and Rogers Venture Partners.

May 30, 2019

Drawbridge falls to LinkedIn

Mitsui has exited customer data platform developer Drawbridge, which was acquired by LinkedIn after raising a reported $70m in venture capital funding.

May 30, 2019

Ayala aligns with corporates for $30m series B

The cancer drug developer has closed a series B round led by development partner Novartis that included Harel Insurance and Finance and SBI JI Innovation Fund.

May 30, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here